Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze NBIX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate NBIX investment potential.

What is NBIX stock price today?

Get real-time NBIX stock price, historical data, and price charts on Financhill. Track NBIX performance with our advanced analysis tools.

Is NBIX a good investment?

Evaluate NBIX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy NBIX stock?

To buy NBIX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of NBIX?

View detailed market capitalization data and company valuation metrics for NBIX on our comprehensive analysis page.

What is the P/E ratio of NBIX?

Use our fundamental analysis tools to view NBIX P/E ratio and compare valuation metrics with industry peers.

What are NBIX earnings?

View NBIX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Neurocrine Biosciences, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

NBIX
Neurocrine Biosciences, Inc.

Last Price:

$131.57

Seasonality Move:

9.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Neurocrine Biosciences, Inc. Stock Forecast

Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 30.6% based on the past 29 years of stock performance.
Neurocrine Biosciences, Inc. has risen higher in 18 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.07%
Is Neurocrine Biosciences, Inc. Stock Undervalued?

The current Neurocrine Biosciences, Inc. [NBIX] share price is $131.60. The Score for NBIX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
NBIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Neurocrine Biosciences, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 30.6% based on the past 29 years of stock performance.

Neurocrine Biosciences, Inc. Stock Rating

Sell

Neurocrine Biosciences, Inc. (NBIX) is a Sell

Is Neurocrine Biosciences, Inc. overpriced?

Neurocrine Biosciences, Inc. has risen higher in 18 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.07%

Neurocrine Biosciences, Inc. Stock Price History

Is NBIX stock going to rise?

The current trend is relatively stagnant and NBIX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

neurocrine.com

52-Week Data

52-Week High:

160.18

52-Week Low:

84.23

Prediction Charts

Market Cap:

13.1B

Price in USD:

131.60

Volume:

706.7K

Beta:

0.78

Technical Analysis

SMA50:

131.92

SMA100:

138.16

SMA200:

137.20

52-Wk Change:

21.5%

Stock Predictions

Is Neurocrine Biosciences, Inc. stock public?

Yes, Neurocrine Biosciences, Inc. is a publicly traded company.
What is the Neurocrine Biosciences, Inc. stock quote today?

The Neurocrine Biosciences, Inc. stock price is 131.60 USD today.
How to buy Neurocrine Biosciences, Inc. stock online?

You can buy Neurocrine Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-16	130.40	129.85	131.89	129.48
Mar-17	130.14	130.71	131.69	129.88
Mar-18	129.95	130.71	131.05	129.01
Mar-19	130.62	129.70	132.25	127.07
Mar-20	128.83	127.68	130.16	126.68
Mar-23	129.65	127.05	130.97	127.03
Mar-24	126.14	127.86	128.31	125.11
Mar-25	128.98	131.13	133.05	128.98
Mar-26	131.13	132.42	133.01	129.96
Mar-27	132.07	128.32	132.95	128.02
Mar-30	129.48	128.72	130.10	128.20
Mar-31	131.74	131.74	133.99	129.97
Apr-1	131.93	132.56	133.40	130.25
Apr-2	130.81	131.60	133.75	130.00

Neurocrine Biosciences, Inc. Earnings

Neurocrine Biosciences, Inc. Earnings Report: Per Share Neurocrine Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurocrine Biosciences, Inc. Forecast Revenue Growth

Neurocrine Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.21 per share, an increase this year of $1.15 per share, and an increase next year of $1.76 per share.

* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.